000 01073 a2200313 4500
005 20250511210129.0
264 0 _c19930208
008 199302s 0 0 eng d
022 _a1040-8746
024 7 _a10.1097/00001622-199112000-00007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaufmann, M
245 0 0 _aAdjuvant therapy for breast cancer.
_h[electronic resource]
260 _bCurrent opinion in oncology
_cDec 1991
300 _a1019-23 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCombined Modality Therapy
650 0 4 _aCost-Benefit Analysis
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aTamoxifen
_xtherapeutic use
650 0 4 _aTime Factors
773 0 _tCurrent opinion in oncology
_gvol. 3
_gno. 6
_gp. 1019-23
856 4 0 _uhttps://doi.org/10.1097/00001622-199112000-00007
_zAvailable from publisher's website
999 _c1849304
_d1849304